Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Leutz, Achim Prof. Dr. (1) Lusatis, Simone (1) Scheidereit, Claus Prof. Dr. (1) (-) Janz, Martin Dr. (6) (-) Mathas, Stephan Dr. (6) (-) Selbach, Matthias Prof. Dr. (6) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (8) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Molekulare Immunologie und Gentherapie (1) (-) Proteom Dynamik (6) 1999 (3) 2000 (1) 2001 (4) 2002 (8) 2003 (4) 2004 (5) (-) 2005 (7) (-) 2006 (7) 2007 (5) 2008 (7) 2009 (10) 2010 (6) 2011 (11) 2012 (6) 2013 (7) 2015 (15) 2016 (11) 2017 (11) 2018 (7) 2019 (6) 2020 (12) 2021 (15) 2022 (17) 2024 (4) 14 Ergebnisse: Active Filter: Janz, Martin Dr.Mathas, Stephan Dr.Selbach, Matthias Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeProteom Dynamik20052006 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 25. August 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. Januar 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch 01. Januar 2005 / Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken 16. März 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann 01. Oktober 2005 / Trends Microbiol Tyrosine-phosphorylated bacterial effector proteins: the enemies within S. Backert M. Selbach 01. August 2005 / Infect Immun Analysis of cell type-specific responses mediated by the type IV secretion system of Helicobacter pylori B. Bauer S. Moese S. Bartfeld T.F. Meyer M. Selbach 01. April 2005 / Trends Microbiol Cortactin: an Achilles' heel of the actin cytoskeleton targeted by pathogens M. Selbach S. Backert Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
25. August 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Januar 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
01. Januar 2005 / Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken
16. März 2006 / Nature Robust Salmonella metabolism limits possibilities for new antimicrobials D. Becker M. Selbach C. Rollenhagen M. Ballmaier T.F. Meyer M. Mann D. Bumann
01. Oktober 2005 / Trends Microbiol Tyrosine-phosphorylated bacterial effector proteins: the enemies within S. Backert M. Selbach
01. August 2005 / Infect Immun Analysis of cell type-specific responses mediated by the type IV secretion system of Helicobacter pylori B. Bauer S. Moese S. Bartfeld T.F. Meyer M. Selbach
01. April 2005 / Trends Microbiol Cortactin: an Achilles' heel of the actin cytoskeleton targeted by pathogens M. Selbach S. Backert